Shenzhen Guangming State-owned Assets Supervision and Administration Bureau completed the acquisition of 65.25% stake in Shenzhen Weiguang Biological Products Co.,Ltd from Shenzhen Guangming Group Co., Ltd.
May 30, 2019
Share
Shenzhen Guangming District Development and Finance Bureau agreed to acquire 65.25% stake in Shenzhen Weiguang Biological Products Co.,Ltd (SZSE:002880) from Shenzhen Guangming Group Co., Ltd. for free on August 29, 2018. Shenzhen Guangming State-owned Assets Supervision and Administration Bureau agreed to acquire 65.25% stake in Shenzhen Weiguang Biological Products Co.,Ltd from Shenzhen Guangming Group Co., Ltd. on April 4, 2019. Under the terms of transaction, Shenzhen Guangming State-owned Assets Supervision and Administration Bureau will acquire 70.5 million shares of Shenzhen Weiguang Biological Products Co.,Ltd. The transaction is subject to approval from Shenzhen State-owned Assets Supervision and Administration Commission, China Securities Regulatory Commission and regulatory approval. The transaction is approved by Shenzhen Guangming Group Co., Ltd. on November 2, 2018. The Shenzhen Guangming District Government approved the transaction on November 28, 2018.
Shenzhen Guangming State-owned Assets Supervision and Administration Bureau completed the acquisition of 65.25% stake in Shenzhen Weiguang Biological Products Co.,Ltd (SZSE:002880) from Shenzhen Guangming Group Co., Ltd. on May 31, 2019.
SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS Co., Ltd. is a China-based high-tech company principally engaged in the research and development, production and sales of biological products. The Companyâs primary products are blood products, including the human serum albumin, human immunoglobulin, intravenous human immunoglobulin, freeze-dried intravenous human immunoglobulin, hepatitis B human immunoglobulin, Rabies immunoglobulin, tetanus immunoglobulin, histamine human immunoglobulin, and human fibrinogen. The Company mainly operates its businesses in domestic market.
Shenzhen Guangming State-owned Assets Supervision and Administration Bureau completed the acquisition of 65.25% stake in Shenzhen Weiguang Biological Products Co.,Ltd from Shenzhen Guangming Group Co., Ltd.
SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD. 
